T1	Premise 707 835	125 of 277 patients (45.1%) experienced pain in the lidocaine group, compared with 123 of 229 patients (53.7%) in the BSS group.
T2	Claim 836 1025	The proportion of patients who experienced pain was significantly lower in the intracameral lidocaine group compared with the BSS group (multivariate OR 0.68, 95% CI 0.47 to 0.97; p=0.034).
T3	Premise 1026 1139	The median pain score (range) was 0.0 for intracameral lidocaine group compared with 1.0 for BSS group (p=0.039).
T4	Premise 1140 1325	Pain was more common in females (54.3% vs 43.6%; OR 1.56), non-Chinese (62.3% vs 46.9%; OR 2.13) and those who had previous cataract surgery to the fellow eye (55.3% vs 44.7%; OR 1.61).
T5	Claim 1326 1477	The use of 0.5 cc of 1% intracameral lidocaine during phacoemulsification under topical anaesthesia significantly reduces pain experienced by patients.
R1	Support Arg1:T1 Arg2:T2	
T6	Claim 1478 1559	Risk factors for pain include females, non-Chinese and previous cataract surgery.
R2	Support Arg1:T4 Arg2:T6	
R3	Support Arg1:T3 Arg2:T5	
